Confidential program
SmartOx
Intelligent oxygen therapy technology.
SmartOx is Dosehost's confidential medical-device program: intelligent technology that adapts home oxygen therapy to each patient. Technical specifications, design, and engineering details are not published.
Why the technical details aren't here
Detailed information is shared only with qualified healthcare partners under a mutual non-disclosure agreement, following a short screening conversation.We keep specifications, design, and engineering detail off the public site on purpose. Protecting the program protects our future partners' edge, too.
The SmartOx program is in active development. It is not yet available for commercial deployment.
Better outcomes, less burden.
A better quality of life
Designed to keep patients safely oxygenated through the demands of daily life, with less worry and more independence.
Lower desaturation risk
Built to reduce the dangerous oxygen drops that drive COPD exacerbations and avoidable hospital visits.
Less daily burden
A simpler home-oxygen experience for patients and caregivers: less to manage, fewer things to get wrong.
Illustrative, not patient data.
Home oxygen is overdue for a rethink.
Overdue for change
Home oxygen therapy has barely changed in decades: manual, disconnected, one-size-fits-all. Patients and providers both feel it.
Connected by design
SmartOx is smart-enabled from the ground up, built for the realities of modern home oxygen therapy.
Evidence first
The clinical case rests on published trials and meta-analyses, and we hold ourselves to that standard as the program develops.
Backed by peer-reviewed research.
Patient outcomes from peer-reviewed clinical research. Full citations available on request.
Built with healthcare organizations.
We're engaging a small group of qualified organizations across home respiratory care as the program develops.
Clinical practices and care organizations
Physician practices, respiratory and rehab groups, and care-management organizations looking to bring smarter oxygen therapy into their programs. In a 2026 survey, 9 in 10 clinicians reacted positively to the concept.
Home oxygen providers
DMEs and HMEs that want to offer patients a more modern oxygen experience, through a simple service relationship with no capital at risk. In a 2026 survey, 96% of providers expected their patients to welcome it.
Health systems and clinical partners
Organizations focused on COPD and respiratory outcomes that want early visibility into what we're building.
A short path for qualified partners.
Reach out
Tell us about your organization and your interest. There are no technical details on this site, and there won't be until we've spoken.
Screening conversation
A brief call to confirm fit, understand your patient population, and answer high-level questions about the program.
Mutual NDA
Qualified partners sign a mutual non-disclosure agreement before any confidential material is shared.
Confidential briefing
We walk you through the SmartOx program, specifications, and the path to a pilot, under NDA.
Interested in SmartOx?
If you're a healthcare organization that wants to learn more, start a conversation. We review every request individually and respond to qualified organizations. No specifications or pricing are shared before a screening conversation and a signed mutual NDA.